Name | 3-[(3R,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile |
---|---|
Synonyms |
(3R,4S)-Tofacitinib|
CS-1109 1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)--oxo-,(3R,4S) 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-((3R,4S)-3-((1H-Indol-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropan-enitrile (3R,4S)-Tofacitinib |
Description | (3R,4S)-Tofacitinib is an enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 585.8±50.0 °C at 760 mmHg |
Molecular Formula | C16H20N6O |
Molecular Weight | 312.370 |
Flash Point | 308.1±30.1 °C |
Exact Mass | 312.169861 |
PSA | 88.91000 |
LogP | 0.93 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.646 |
Storage condition | -20°C |